MedPath

Luprodex

Brand Name: Luprodex

Generic Name: Leuprorelin Acetate

Active
Registration Number

DR-XY48476

Dosage Form

Lyophilized Powder For Injection (IM/SC)

Issuance Date

November 18, 2022

Expiry Date

November 18, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength11.25 mg
PackagingEach box contains the following in PVC tray: 1. 5 mL USP Type I glass vial with bromobutyl rubber stopper, and white aluminum flip-off seal x 1's 2. 2 mL USP type I ampoule (diluent) x 1's 3. 3 mL syringe x 1's 4. 22G needle x 2's 5. alcohol swabs x 2's

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Leuprorelin AcetateActive
Monograph: Leuprolide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform